Ledger.Open graph →
SEC Form D · filed July 29, 2020

Perfuse Therapeutics, Inc

Offering
$39.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christy Shaffer · San Francisco, CADirectorSevgi Gurkan · San Francisco, CAExec · Director · PromoterChau Khuong · San Francisco, CADirectorBrian Greene · Brentwood, CADirectorKevin Derr · Brentwood, CADirectorAdam Brothers · Roseland, NJExec · Director · PromoterHongbo Lu · Santa Clara, CADirectorDan Becker · GOLDEN, CODirectorJerry Cagle · San Francisco, CADirectorBrett J. Wyss · Colorado Springs, CODirectorJames W. Wyss · Colorado Springs, CODirectorRandall B. Rush · Colorado Springs, COExec · Director · PromoterHongbo Lu · Waltham, MADirectorDan Becker · GOLDEN, CODirectorJerry Cagle · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗